Discontinuation report LARTRUVO

Last updated on 2020-10-05 History
Report ID 124196
Drug Identification Number 02480271
Brand name LARTRUVO
Common or Proper name OLARATUMAB
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) OLARATUMAB
Strength(s) 190MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 Vial, 190 MG / 19 ML
ATC code L01XC
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-10-22
Actual discontinuation date 2020-09-25
Remaining supply date 2020-09-25
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Lilly Canada’s Customer Response Centre 1-888-545-5972.
Health Canada comments
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-09-14 English Compare
v2 2020-09-14 French Compare
v3 2020-10-05 English Compare
v4 2020-10-05 French Compare